We endeavor to conduct a portfolio of Long COVID clinical trials within our Long COVID Treatment Trial (LoCITT) program, operated by Scripps Research in partnership with CareEvolution and funded by the Schmidt Initiative for Long COVID (SILC). This work is crucial given the global burden of Long COVID, with over 400 million individuals affected, several mechanisms involved in contributing to over 200 symptoms, and no FDA approved treatments.
Be part of groundbreaking Long COVID research from Scripps Research
Current Studies
“The fact that it is being looked at is huge. This condition is scary because there are so many symptoms and doctors don’t know what to expect, so collecting this data is so important because it has the potential to be so impactful for so many people.”
Estela Mata
Long COVID user tester
About LoCITT
The Long COVID research program at Scripps has:
- Remote participation options
- Participants living in the U.S.
- Real-world data collected via digital health tools
Private and Trusted
LoCITT is run by Scripps Research, a leading nonprofit academic institution with a focus on research and education in biomedical sciences. Our researchers lead breakthrough studies that address the world’s most pressing health concerns.
As a trusted nonprofit organization, your privacy is our priority. In order to protect you, your name and personal information are removed from your data prior to it reaching our researchers.
Easy, Free and Convenient
If you live in the United States and have a smartphone, you can download the MyDataHelps™ app to participate.
![]()
Download App
![]()
Connect Devices
![]()
Share Health Records
![]()
Fill Out Surveys
![]()
Get Data and Recommendations
Join the Long COVID Treatment Trial (LoCITT) waitlist
We are beginning a waitlist of people who are interested in participating to contribute to the advancement of Long COVID and infection-associated chronic conditions research.
You can sign up to receive updates on our Long COVID clinical trials and be notified before a clinical trial launches.
You can be removed from the waitlist by:
- Contacting the research team at longcovid@scripps.edu
- You will no longer be contacted about new research opportunities
Join Our Early Experience Tester Program
We’re looking for volunteers to try out new features before they launch. Sign up to be among the first to explore the Long COVID Treatment Trial experience and help us make it better for everyone.
Contact Us
For questions regarding this program, please contact us by email at longcovid@scripps.edu.
News & Media
2025 Year in Review: Five insights we’re still thinking about
Scripps Research: Science Changing Life Podcast
Webinar: Long COVID Treatment Trial-Trizepatide (LoCITT-T): Study Update & Live Q&A (Dec. 17, 2025)
Scripps Research
Inside the GLP-1 Study for Long COVID, with lead scientist Dr Julia Vogel, Long Covid, MD Pod, Ep 61
LongCovidMD
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
Wired
Dr. Julia Moore Vogel – Scripps Research – Visionary, Patient-Centric Health Research For All
Progress, Potential, and Possibilities
Scientists launch new trial for long COVID treatment
KPBS Midday Edition
Webinar: Long COVID Treatment Trial-Tirzepatide (LoCITT-T): Learn How to Participate From Home (Nov. 5, 2025)
Scripps Research
Researchers launch new study to test popular weight-loss drugs for long COVID treatment
WDIV Local 4 / ClickOnDetroit
Researchers at Scripps test weight-loss drug for long COVID relief
41NBC Georgia
Scripps researchers investigate whether weight loss drugs could improve long COVID symptoms
KYMA Arizona
Tuesday’s Daily Dose with Monica Robins: Veterans face skin cancer risk, long COVID drug trial launches and measles cases surge
WKYC Studios Ohio
We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.
The Sick Times
Obesity drug seen as effective for Long COVID, gets clinical trial
KPBS
Could GLP-1 weight loss drugs treat long-haul COVID
NBC 7 San Diego
Can a weight loss and diabetes drug treat Long COVID?
The San Diego Union-Tribune
Scripps Research scientists launch new digital clinical trial to test repurposed drug for Long COVID symptom relief
Scripps Research
Webinar: Introducing the Long COVID Treatment Trial (LoCITT)
Scripps Research
Remote Long COVID trial to evaluate repurposed drug across US
ContagionLive
“The field is coming of age”: Long COVID researchers gather in Santa Fe to foster collaboration
Sick Times
Long COVID patients can sign up for remote clinical trial notification
The Schmidt Initiative for Long COVID
The long haul: Personal and scientific insights into long COVID with Julia Moore Vogel
Scripps Research: Science Changing Life Podcast
